Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma
Tuesday, June 10, 2008 10:11 AM
Symbols: GSK
Optimaltherapy for many patients with persistent moderate to severe asthma requirestreatment of both these components.


The study was designed to primarily show that Advair improved the rate ofexacerbations compared to Flovent. While Advair patients had a lowerexacerbation rate than those patients in the Flovent group, the difference wasnot statistically significant. On most of the secondary endpoints, patientsgiven Advair performed better than patients who used Flovent. Forcedexpiratory volume in one second (FEV1) improved in Advair patients. Bothmorning and evening peak expiratory flow (PEF) were also improved in theAdvair group. Patients using Advair were also less likely to awake at nightdue to asthma-related breathing difficulties. Additionally, the Advair groupshowed reductions in the rate of daily symptoms and the need for a rescueinhaler.


Both Advair and Flovent were well tolerated. Over a one-year period, theoverall incidence of adverse events was similar between the two groups.


Important Information about Advair Diskus


Advair Diskus won't replace fast-acting inhalers for sudden symptoms andshould not be taken more than twice a day. Advair Diskus contains salmeterol.In patients with asthma, medicines like salmeterol may increase the chance ofasthma-related death. So Advair Diskus is not for people whose asthma is wellcontrolled on another controller medicine. People should speak to their doctorabout the risks and benefits of treating their asthma with Advair Diskus.People taking Advair Diskus should see their doctor if their asthma does notimprove. People should tell their doctor if they have a heart condition orhigh blood pressure. Some people may experience increased blood pressure,heart rate, or changes in heart rhythm. Advair Diskus is for patients 4 yearsand older. For patients 4 to 11 years old, Advair Diskus 100/50 is for thosewho have asthma symptoms while on an inhaled corticosteroid.


About GlaxoSmithKline


GlaxoSmithKline is one of the world's leading research-basedpharmaceutical and healthcare companies. GlaxoSmithKline is committed toimproving the quality of human life by enabling people to do more, feel betterand live longer. For company information visit http://www.gsk.com.


SOURCE GlaxoSmithKline


(Source: PR Newswire )

<< Previous Page

More Options




Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 300 contributors and press releases, SEC filings and full text news from thousands of sources.


 
Rate :  Rate this Commentary  


 Number of Comments (0) Post Comment
 
  
Good Rating(+1)    Bad Rating(-1)
No Data Found

 
Enter Symbol
Enter Search String
Bookmark This Article
Email Article

Send this article by email


Recipient's Name
Recipient's E-mail
Your Name
Your E-mail
Alerts by Email
Research Articles
Stock Ranking Changes
Related RSS Feeds


 
  Home | Login |Research | Earnings | Scans | Chat Rooms | Charts | Submit Article | Join Blog Network | Contributors | Subscribe to RSS

copryright 2008 all rights reserved